Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Lung cell exposure to secondary photochemical aerosols generated from OH oxidation of cyclic siloxanes.

King BM, Janechek NJ, Bryngelson N, Adamcakova-Dodd A, Lersch T, Bunker K, Casuccio G, Thorne PS, Stanier CO, Fiegel J.

Chemosphere. 2019 Oct 15;241:125126. doi: 10.1016/j.chemosphere.2019.125126. [Epub ahead of print]

PMID:
31683444
2.

Mitsui-7, heat-treated, and nitrogen-doped multi-walled carbon nanotubes elicit genotoxicity in human lung epithelial cells.

Siegrist KJ, Reynolds SH, Porter DW, Mercer RR, Bauer AK, Lowry D, Cena L, Stueckle TA, Kashon ML, Wiley J, Salisbury JL, Mastovich J, Bunker K, Sparrow M, Lupoi JS, Stefaniak AB, Keane MJ, Tsuruoka S, Terrones M, McCawley M, Sargent LM.

Part Fibre Toxicol. 2019 Oct 7;16(1):36. doi: 10.1186/s12989-019-0318-0.

3.

Acid-Induced Liberation of Polysubstituted Cyclopentadiene Ligands from Cyclopentadienyl Cobalt: A [2 + 2 + 1] Cycloaddition Route toward 1,2,4-Trisubstituted Cyclopentadienes.

Qin P, Holland RL, Bunker KD, O'Connor JM, Baldridge KK, Rheingold AL.

J Org Chem. 2019 Nov 1;84(21):13992-14004. doi: 10.1021/acs.joc.9b02182. Epub 2019 Oct 3.

PMID:
31549512
4.

In Vivo Toxicity Assessment of Occupational Components of the Carbon Nanotube Life Cycle To Provide Context to Potential Health Effects.

Bishop L, Cena L, Orandle M, Yanamala N, Dahm MM, Birch ME, Evans DE, Kodali VK, Eye T, Battelli L, Zeidler-Erdely PC, Casuccio G, Bunker K, Lupoi JS, Lersch TL, Stefaniak AB, Sager T, Afshari A, Schwegler-Berry D, Friend S, Kang J, Siegrist KJ, Mitchell CA, Lowry DT, Kashon ML, Mercer RR, Geraci CL, Schubauer-Berigan MK, Sargent LM, Erdely A.

ACS Nano. 2017 Sep 26;11(9):8849-8863. doi: 10.1021/acsnano.7b03038. Epub 2017 Aug 4.

PMID:
28759202
5.

Occupational exposure to nanoparticles at commercial photocopy centers.

Martin J, Bello D, Bunker K, Shafer M, Christiani D, Woskie S, Demokritou P.

J Hazard Mater. 2015 Nov 15;298:351-60. doi: 10.1016/j.jhazmat.2015.06.021. Epub 2015 Jun 17.

PMID:
26148960
6.

Consumer exposures to laser printer-emitted engineered nanoparticles: A case study of life-cycle implications from nano-enabled products.

Pirela SV, Sotiriou GA, Bello D, Shafer M, Bunker KL, Castranova V, Thomas T, Demokritou P.

Nanotoxicology. 2015;9(6):760-8. doi: 10.3109/17435390.2014.976602. Epub 2014 Nov 11.

7.

Genotoxicity of multi-walled carbon nanotubes at occupationally relevant doses.

Siegrist KJ, Reynolds SH, Kashon ML, Lowry DT, Dong C, Hubbs AF, Young SH, Salisbury JL, Porter DW, Benkovic SA, McCawley M, Keane MJ, Mastovich JT, Bunker KL, Cena LG, Sparrow MC, Sturgeon JL, Dinu CZ, Sargent LM.

Part Fibre Toxicol. 2014 Jan 30;11:6. doi: 10.1186/1743-8977-11-6.

8.

Design of potent and selective inhibitors to overcome clinical anaplastic lymphoma kinase mutations resistant to crizotinib.

Huang Q, Johnson TW, Bailey S, Brooun A, Bunker KD, Burke BJ, Collins MR, Cook AS, Cui JJ, Dack KN, Deal JG, Deng YL, Dinh D, Engstrom LD, He M, Hoffman J, Hoffman RL, Johnson PS, Kania RS, Lam H, Lam JL, Le PT, Li Q, Lingardo L, Liu W, Lu MW, McTigue M, Palmer CL, Richardson PF, Sach NW, Shen H, Smeal T, Smith GL, Stewart AE, Timofeevski S, Tsaparikos K, Wang H, Zhu H, Zhu J, Zou HY, Edwards MP.

J Med Chem. 2014 Feb 27;57(4):1170-87. doi: 10.1021/jm401805h. Epub 2014 Feb 6.

9.

Single-walled carbon nanotube-induced mitotic disruption.

Sargent LM, Hubbs AF, Young SH, Kashon ML, Dinu CZ, Salisbury JL, Benkovic SA, Lowry DT, Murray AR, Kisin ER, Siegrist KJ, Battelli L, Mastovich J, Sturgeon JL, Bunker KL, Shvedova AA, Reynolds SH.

Mutat Res. 2012 Jun 14;745(1-2):28-37. doi: 10.1016/j.mrgentox.2011.11.017. Epub 2011 Dec 8.

10.

Scalable synthesis of 1-bicyclo[1.1.1]pentylamine via a hydrohydrazination reaction.

Bunker KD, Sach NW, Huang Q, Richardson PF.

Org Lett. 2011 Sep 2;13(17):4746-8. doi: 10.1021/ol201883z. Epub 2011 Aug 11.

PMID:
21834522
11.

Blood glucose meters.

Bunker K, Toves K.

Diabetes Forecast. 2011 Jan;64(1):30-2, 35-43. No abstract available. Erratum in: Diabetes Forecast. 2011 Feb;64(2):15.

PMID:
21337828
12.

Health care reform and you.

Bunker K.

Diabetes Forecast. 2010 Sep;63(9):44-8. No abstract available.

PMID:
20839605
13.

Characterization of exposures to airborne nanoscale particles during friction stir welding of aluminum.

Pfefferkorn FE, Bello D, Haddad G, Park JY, Powell M, McCarthy J, Bunker KL, Fehrenbacher A, Jeon Y, Virji MA, Gruetzmacher G, Hoover MD.

Ann Occup Hyg. 2010 Jul;54(5):486-503. doi: 10.1093/annhyg/meq037. Epub 2010 May 7.

14.

2-Chloro-4-(1H-pyrazol-1-yl)-5-(trifluoro-meth-yl)pyrimidine.

Bunker KD, Moore C, Palmer CL, Rheingold AL, Yanovsky A.

Acta Crystallogr Sect E Struct Rep Online. 2010 May 26;66(Pt 6):o1448. doi: 10.1107/S1600536810018854.

15.

Defeating discrimination. A new law protects people with diabetes in the workplace and beyond.

Bunker K.

Diabetes Forecast. 2009 May;62(5):40-6. No abstract available.

PMID:
19499597
16.

Dealing with diabetes. Reaching out can help you cope--and thrive.

Bunker K.

Diabetes Forecast. 2009 Apr;62(4):54-5. No abstract available.

PMID:
19445078
17.

What's covered? Don't wait to ask your health insurance provider.

Bunker K.

Diabetes Forecast. 2009 Apr;62(4):51-3. No abstract available.

PMID:
19445077
18.

4-Chloro-7-hydr-oxy-6-methyl-1,7-naphthyridin-8(7H)-one.

Bunker KD, Nukui S, Rheingold AL, Dipasquale A, Yanovsky A.

Acta Crystallogr Sect E Struct Rep Online. 2009 Nov 28;65(Pt 12):o3259. doi: 10.1107/S1600536809050429.

19.

A new number. "Average glucose" will soon be a key part of your diabetes tool kit.

Bunker K.

Diabetes Forecast. 2008 Nov;61(11):74-5. No abstract available.

PMID:
19054872
20.

Where we've been...60 years of Diabetes Forecast.

Bunker K, Harsh AK.

Diabetes Forecast. 2008 Oct;61(10):69-71. No abstract available.

PMID:
18942214
21.

Reactions of a metallacyclobutene complex with alkenes.

Holland RL, Bunker KD, Chen CH, DiPasquale AG, Rheingold AL, Baldridge KK, O'Connor JM.

J Am Chem Soc. 2008 Aug 6;130(31):10093-5. doi: 10.1021/ja803701z. Epub 2008 Jul 11.

PMID:
18616253
22.

Happy campers. Get your child ready for a fun-filled summer.

Bunker K.

Diabetes Forecast. 2008 May;61(5):46-8. No abstract available.

PMID:
18499926
23.

Why heart rates matter.

Bunker K.

Diabetes Forecast. 2008 May;61(5):27. No abstract available.

PMID:
18499921
24.

30 things you should know about managing diabetes.

Bunker K.

Diabetes Forecast. 2008 Apr;61(4):54-6. No abstract available.

PMID:
18478645
25.

Very low birth weight, later diabetes?

Bunker K.

Diabetes Forecast. 2008 Apr;61(4):27. No abstract available.

PMID:
18478639
26.

Naturally occurring asbestos: a recurring public policy challenge.

Lee RJ, Strohmeier BR, Bunker KL, Van Orden DR.

J Hazard Mater. 2008 May 1;153(1-2):1-21. doi: 10.1016/j.jhazmat.2007.11.079. Epub 2007 Nov 28. Review.

PMID:
18180100
27.

3-Amino-5-bromo-2-iodo-pyridine.

Bunker KD, Sach NW, Nukui S, Rheingold AL, Yanovsky A.

Acta Crystallogr Sect E Struct Rep Online. 2008 Dec 6;65(Pt 1):o28. doi: 10.1107/S1600536808040452.

28.

Back-to-school survival guide. A team effort. For one family, diabetes is the name of the game.

Bunker K.

Diabetes Forecast. 2007 Sep;60(10):54-5. No abstract available.

PMID:
17941148
29.

The questions you don't ask. A new book from ADA looks at how you can achieve diabetes management in 10 steps.

Bunker K.

Diabetes Forecast. 2007 Jun;60(7):57-8. No abstract available.

PMID:
17632930
30.

Accessing and recruiting children for research in schools.

Rice M, Bunker KD, Kang DH, Howell CC, Weaver M.

West J Nurs Res. 2007 Jun;29(4):501-14.

PMID:
17538129
31.

Sulfoxide carbon-sulfur bond activation.

O'Connor JM, Bunker KD, Rheingold AL, Zakharov L.

J Am Chem Soc. 2005 Mar 30;127(12):4180-1.

PMID:
15783194
32.

Ring-strain effects on the oxidation potential of enediynes and enediyne complexes.

Baldridge KK, Donovan-Merkert BT, O'Connor JM, Lee LI, Closson A, Fandrick D, Tran T, Bunker KD, Fouzi M, Gantzel P.

Org Biomol Chem. 2003 Mar 7;1(5):763-6.

PMID:
12929356
33.

The young and the clueless.

Bunker KA, Kram KE, Ting S.

Harv Bus Rev. 2002 Dec;80(12):80-7, 133.

PMID:
12510540
34.

Absolute bioavailability of 2'-O-(2-methoxyethyl)-modified antisense oligonucleotides following intraduodenal instillation in rats.

Geary RS, Khatsenko O, Bunker K, Crooke R, Moore M, Burckin T, Truong L, Sasmor H, Levin AA.

J Pharmacol Exp Ther. 2001 Mar;296(3):898-904.

PMID:
11181922
35.

A child with Noonan syndrome.

Hopkins-Acos P, Bunker K.

J Speech Hear Disord. 1979 Nov;44(4):494-503.

PMID:
513672

Supplemental Content

Loading ...
Support Center